ENTX
Price
$2.07
Change
+$0.06 (+2.99%)
Updated
Jun 6 closing price
Capitalization
94.09M
62 days until earnings call
TELIF
Price
$0.29
Change
+$0.01 (+3.57%)
Updated
Jun 6 closing price
Capitalization
15.9M
Interact to see
Advertisement

ENTX vs TELIF

Header iconENTX vs TELIF Comparison
Open Charts ENTX vs TELIFBanner chart's image
Entera Bio
Price$2.07
Change+$0.06 (+2.99%)
Volume$34.32K
Capitalization94.09M
TELESCOPE INNOVATIONS
Price$0.29
Change+$0.01 (+3.57%)
Volume$75.96K
Capitalization15.9M
ENTX vs TELIF Comparison Chart
Loading...
ENTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTX vs. TELIF commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTX is a StrongBuy and TELIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (ENTX: $2.07 vs. TELIF: $0.29)
Brand notoriety: ENTX and TELIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTX: 80% vs. TELIF: 233%
Market capitalization -- ENTX: $94.09M vs. TELIF: $15.9M
ENTX [@Biotechnology] is valued at $94.09M. TELIF’s [@Biotechnology] market capitalization is $15.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTX’s FA Score shows that 0 FA rating(s) are green whileTELIF’s FA Score has 0 green FA rating(s).

  • ENTX’s FA Score: 0 green, 5 red.
  • TELIF’s FA Score: 0 green, 5 red.
According to our system of comparison, TELIF is a better buy in the long-term than ENTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTX’s TA Score shows that 5 TA indicator(s) are bullish.

  • ENTX’s TA Score: 5 bullish, 5 bearish.

Price Growth

ENTX (@Biotechnology) experienced а +12.20% price change this week, while TELIF (@Biotechnology) price change was +34.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

ENTX is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENTX($94.1M) has a higher market cap than TELIF($15.9M). TELIF YTD gains are higher at: 10.008 vs. ENTX (-2.358). TELIF has higher annual earnings (EBITDA): -1.07M vs. ENTX (-9.16M). ENTX has more cash in the bank: 6.92M vs. TELIF (963K). ENTX has less debt than TELIF: ENTX (309K) vs TELIF (2.15M). TELIF has higher revenues than ENTX: TELIF (4.12M) vs ENTX (99K).
ENTXTELIFENTX / TELIF
Capitalization94.1M15.9M592%
EBITDA-9.16M-1.07M854%
Gain YTD-2.35810.008-24%
P/E RatioN/A85.38-
Revenue99K4.12M2%
Total Cash6.92M963K718%
Total Debt309K2.15M14%
FUNDAMENTALS RATINGS
ENTX: Fundamental Ratings
ENTX
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ENTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EUSA97.340.79
+0.82%
iShares MSCI USA Equal Weighted ETF
FLUD24.900.03
+0.13%
Franklin Ultra Short Bond ETF
CADHKD5.74N/A
N/A
Canadian Dollar - Hong Kong Dollar
MYN9.43N/A
N/A
Blackrock Muniyield NEW York Quality Fund
DRIP10.41-0.51
-4.67%
Direxion Dly S&P Oil&Gs Ex&Prd Br 2X ETF

ENTX and

Correlation & Price change

A.I.dvisor tells us that ENTX and JSPR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ENTX and JSPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTX
1D Price
Change %
ENTX100%
+2.99%
JSPR - ENTX
32%
Poorly correlated
+5.44%
STOK - ENTX
32%
Poorly correlated
+2.39%
OPORF - ENTX
31%
Poorly correlated
N/A
ORKA - ENTX
29%
Poorly correlated
+3.20%
XENE - ENTX
29%
Poorly correlated
+2.96%
More

TELIF and

Correlation & Price change

A.I.dvisor tells us that TELIF and ATNM have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELIF and ATNM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELIF
1D Price
Change %
TELIF100%
+1.31%
ATNM - TELIF
31%
Poorly correlated
+8.28%
RVXCF - TELIF
22%
Poorly correlated
N/A
ENTX - TELIF
20%
Poorly correlated
+2.99%
ACUT - TELIF
11%
Poorly correlated
+5.20%
REVB - TELIF
9%
Poorly correlated
+5.45%
More